For instance, the more pronounced protective effect against lymphoid and hematopoietic cancers in males compared to females suggests potential interactions between GLP-1R signaling and sex-specific physiological factors. This evidence concerns the gene GLP1R and hematopoietic and lymphoid cell neoplasm.